Comments
Loading...

Zevra Therapeutics

ZVRANASDAQ
Logo brought to you by Benzinga Data
$8.49
-0.05-0.59%
At close: -
$8.72
0.232.71%
After Hours: 7:23 PM EDT

Zevra Therapeutics (NASDAQ:ZVRA) Stock Quotes, Forecast and News Summary

Zevra Therapeutics Stock (NASDAQ: ZVRA) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jul
3
Aug
5
Sep
3
Oct
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$8.43
Close$8.49
Volume / Avg.2.54M / 818.91K
Day Range$8.34 - $8.83
52 Wk Range4.20 - 9.76
Market Cap$465.44M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
49
Short Interest
8.09%
Days to Cover7.99

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ZVRA
AVIR

FAQ

Q

How do I buy Zevra Therapeutics (ZVRA) stock?

A

You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Zevra Therapeutics (ZVRA) competitors?

Q

What is the forecast, or price target, for Zevra Therapeutics (ZVRA) stock?

A

Zevra Therapeutics has a consensus price target of $21.00.

Q

What is the current price for Zevra Therapeutics (ZVRA)?

A

The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $8.72 last updated December 20, 2024 at 7:23 PM EST.

Q

Does Zevra Therapeutics (ZVRA) pay a dividend?

A

There are no upcoming dividends for Zevra Therapeutics.

Q

When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?

A

Zevra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Q

Is Zevra Therapeutics (ZVRA) going to split?

A

There is no upcoming split for Zevra Therapeutics.

Q

What sector and industry does Zevra Therapeutics (ZVRA) operate in?

A

Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch